Literature DB >> 1676170

Latent inhibition is unaffected by direct dopamine agonists.

J Feldon1, A Shofel, I Weiner.   

Abstract

Latent inhibition (LI) refers to the finding that nonreinforced preexposure to a stimulus retards subsequent conditioning to that stimulus when it is paired with reinforcement. The development of LI reflects a process of learning not to attend, or ignore, irrelevant stimuli. Previous experiments showed that LI was disrupted by low but not high doses of amphetamine, and facilitated by neuroleptic drugs. The present experiments sought to investigate the role of dopamine D1 and D2 receptors in LI disruption. Experiments 1 and 2 showed that the selective D1 agonist, SKF-38393 (1, 5, 10 mg/kg) and the selective D2 agonist, quinpirole (0.1, 0.3, 1.0 mg/kg), did not affect LI. Experiment 3 showed that both low (0.3 mg/kg) and high (1.5 mg/kg) doses of the mixed D1-D2 agonist, apomorphine, failed to affect L1. These results show that L1 is not disrupted by direct stimulation of DA receptors and suggest that the differential effect exerted on this phenomenon by apomorphine (and possibly SKF-38393 and quinpirole) and amphetamine is related to the direct versus the indirect agonist action of these drugs. In addition, apomorphine at the dose of 0.03 mg/kg, which is believed to activate preferentially DA autoreceptors, did not produce neuroleptic-like facilitation of LI. The implications of the results of the involvement of DA mechanisms in L1 are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676170     DOI: 10.1016/0091-3057(91)90283-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

1.  Latent inhibition: interpretation of amphetamine effects in novel paradigms.

Authors:  M H Joseph
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

2.  A rat model of distractibility: effects of drugs modifying dopaminergic, noradrenergic and GABAergic neurotransmission.

Authors:  A Agmo; C Belzung; C Rodríguez
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Involvement of different types of dopamine receptors in the formation of latent inhibition of a conditioned passive avoidance reaction in rats.

Authors:  L V Loskutova; N V Kostyunina; N I Dubrovina
Journal:  Neurosci Behav Physiol       Date:  2010-05-21

Review 4.  The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Authors:  Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

5.  Differences in serotonin and dopamine metabolism in the rat brain in latent inhibition.

Authors:  G F Molodtsova
Journal:  Neurosci Behav Physiol       Date:  2003-03

6.  Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction.

Authors:  A S Killcross; A Dickinson; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

7.  Dopamine D1 receptor involvement in latent inhibition and overshadowing.

Authors:  Andrew J D Nelson; Karen E Thur; Helen J Cassaday
Journal:  Int J Neuropsychopharmacol       Date:  2011-12-16       Impact factor: 5.176

8.  Reduced dopamine function within the medial shell of the nucleus accumbens enhances latent inhibition.

Authors:  A J D Nelson; K E Thur; R R Horsley; C Spicer; C A Marsden; H J Cassaday
Journal:  Pharmacol Biochem Behav       Date:  2010-12-10       Impact factor: 3.533

9.  Opposing effects of 5,7-DHT lesions to the core and shell of the nucleus accumbens on the processing of irrelevant stimuli.

Authors:  Andrew J D Nelson; Karen E Thur; Charles A Marsden; Helen J Cassaday
Journal:  Int J Neuropsychopharmacol       Date:  2011-04-18       Impact factor: 5.176

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.